These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. The impact of tumor stage on prognosis in children with adrenocortical carcinoma. Tucci S; Martins AC; Suaid HJ; Cologna AJ; Reis RB J Urol; 2005 Dec; 174(6):2338-42, discussion 2342. PubMed ID: 16280838 [TBL] [Abstract][Full Text] [Related]
24. A clinicopathologic profile of adrenocortical tumors. Upadhye PS; Desai MP; Colaco MP; Desai PB; Deshpande RK; Mokal RA Indian Pediatr; 1997 Jun; 34(6):481-90. PubMed ID: 9357203 [TBL] [Abstract][Full Text] [Related]
25. Novel and existing mutations in the tyrosine kinase domain of the epidermal growth factor receptor are predictors of optimal resectability in malignant peritoneal mesothelioma. Foster JM; Gatalica Z; Lilleberg S; Haynatzki G; Loggie BW Ann Surg Oncol; 2009 Jan; 16(1):152-8. PubMed ID: 18998063 [TBL] [Abstract][Full Text] [Related]
26. Adrenocortical carcinomas: surgical trends and results of a 253-patient series from the French Association of Endocrine Surgeons study group. Icard P; Goudet P; Charpenay C; Andreassian B; Carnaille B; Chapuis Y; Cougard P; Henry JF; Proye C World J Surg; 2001 Jul; 25(7):891-7. PubMed ID: 11572030 [TBL] [Abstract][Full Text] [Related]
27. Adrenocortical tumors in Italian children: analysis of clinical characteristics and P53 status. Data from the national registries. Dall'Igna P; Virgone C; De Salvo GL; Bertorelle R; Indolfi P; De Paoli A; Buffa P; Conte M; Esposito G; Inserra A; Candiotto C; D'Onofrio V; Boldrini R; Ferrari A; Bisogno G; Alaggio R; Cecchetto G J Pediatr Surg; 2014 Sep; 49(9):1367-71. PubMed ID: 25148739 [TBL] [Abstract][Full Text] [Related]
33. Contribution of the TP53 R337H mutation to the cancer burden in southern Brazil: Insights from the study of 55 families of children with adrenocortical tumors. Mastellaro MJ; Seidinger AL; Kang G; Abrahão R; Miranda ECM; Pounds SB; Cardinalli IA; Aguiar SS; Figueiredo BC; Rodriguez-Galindo C; Brandalise SR; Yunes JA; Barros-Filho AA; Ribeiro RC Cancer; 2017 Aug; 123(16):3150-3158. PubMed ID: 28387921 [TBL] [Abstract][Full Text] [Related]
34. Adrenocortical neoplasms in young children: age as a prognostic factor. Ahmed AA Ann Clin Lab Sci; 2009; 39(3):277-82. PubMed ID: 19667412 [TBL] [Abstract][Full Text] [Related]
35. [Treatment outcome of children and adolescents with germ cell tumor after combined therapy---a report of 44 cases]. Sun XF; Yang QY; Zhen ZJ; Xia Y; Huang ZH; Ling JY Ai Zheng; 2006 Dec; 25(12):1529-32. PubMed ID: 17166380 [TBL] [Abstract][Full Text] [Related]
36. Esthesioneuroblastoma in childhood and adolescence. Better prognosis with multimodal treatment? Eich HT; Müller RP; Micke O; Kocher M; Berthold F; Hero B Strahlenther Onkol; 2005 Jun; 181(6):378-84. PubMed ID: 15925980 [TBL] [Abstract][Full Text] [Related]
37. Somatic TP53 mutations are relatively rare among adrenocortical cancers with the frequent 17p13 loss of heterozygosity. Libè R; Groussin L; Tissier F; Elie C; René-Corail F; Fratticci A; Jullian E; Beck-Peccoz P; Bertagna X; Gicquel C; Bertherat J Clin Cancer Res; 2007 Feb; 13(3):844-50. PubMed ID: 17289876 [TBL] [Abstract][Full Text] [Related]
38. Response to mitotane predicts outcome in patients with recurrent adrenal cortical carcinoma. Gonzalez RJ; Tamm EP; Ng C; Phan AT; Vassilopoulou-Sellin R; Perrier ND; Evans DB; Lee JE Surgery; 2007 Dec; 142(6):867-75; discussion 867-75. PubMed ID: 18063070 [TBL] [Abstract][Full Text] [Related]